Eyes on the target: Drug discovery’s new paradigm

Editor in Chief Simone Fishburn selected this story as one of BioCentury's Best of 2024. To see the full list, click here.

If success in creating groundbreaking therapies boils down to one thing, it can be argued that it’s about picking the right target. From there cascade the modality, indication, patient population and other features that define the product, but none of it matters if the target is wrong. ...